These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II]. Lunetta M; Presti C; Mughini MT; Mughini L Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864 [No Abstract] [Full Text] [Related]
6. [Glucose-lactic acid metabolism during clinical use of biguanides]. Pedersen J Ugeskr Laeger; 1973 Jul; 135(31):1632-5. PubMed ID: 4585752 [No Abstract] [Full Text] [Related]
7. [Risk of lactic acidosis in phenformin-treated diabetics]. Frank-Piskorska A; Barańska H; Jung M; Bartnikowska E Pol Tyg Lek; 1980 Jul; 35(28):1055-7. PubMed ID: 6776503 [No Abstract] [Full Text] [Related]
8. [Study of disturbances of lactic acid metabolism in diabetes mellitus]. Debry G; Cherrier P; Laurent J Pathol Biol; 1966 Jan; 14(1):13-21. PubMed ID: 5323705 [No Abstract] [Full Text] [Related]
9. [On the therapy of diabetes mellitus with biguanides]. Riess PJ; Saum R Med Klin; 1968 May; 63(19):764-7. PubMed ID: 5730198 [No Abstract] [Full Text] [Related]
10. [Effect of intravenous administration of N 1-n-butylbiguanide on carbohydrate and lipid metabolism in diabetics]. Michaelis D; Lippmann HG; Köhler E Dtsch Gesundheitsw; 1970 May; 25(19):870-4. PubMed ID: 5523783 [No Abstract] [Full Text] [Related]
12. [Lactic acidosis due to biguanides]. Mascetti R; Mascetti P Minerva Med; 1972 Oct; 63(72):3930-8. PubMed ID: 4628076 [No Abstract] [Full Text] [Related]
13. [Effects of some oral hypoglycemia drugs on blood levels of lactic and pyruvic acid in diabetes mellitus]. Sgambato S; Bisesti V; Giugliano D; Passariello N; Saccomanno F Clin Ter; 1980 Apr; 93(2):183-92. PubMed ID: 7449337 [No Abstract] [Full Text] [Related]
14. Biguanides. A review of history, pharmacodynamics and therapy. Schäfer G Diabete Metab; 1983; 9(2):148-63. PubMed ID: 6352352 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the risk of lactic acidosis in the treatment of diabetes with biguanides]. Marigo S; Marongiu C; Donadoni R Clin Ter; 1983 May; 105(3):227-42. PubMed ID: 6411420 [No Abstract] [Full Text] [Related]
16. [A contribution to the study of the effect of bigvanides in the skeletal muscle of diabetics (author's transl)]. Vondra K; Bass A; Brunová E; Slabochová Z; Teisinger J; Vítek V Cas Lek Cesk; 1978 Jul; 117(29-30):892-4. PubMed ID: 688313 [No Abstract] [Full Text] [Related]
17. [Therapeutic possibilities in diabetes mellitus with biguanides. Clinical experiences in 122 diabetics with dimethylbiguanide(Glucophage)]. Berger W; Constam GR; Siegenthaler W Schweiz Med Wochenschr; 1966 Oct; 96(40):1335-42. PubMed ID: 5954279 [No Abstract] [Full Text] [Related]
19. [Repeated determination of fasting insulin-like activity in persons with normal metabolism and in untreated and orally treated diabetics. (Preliminary report)]. Klein W Dtsch Med J; 1966 Nov; 17(22):664-71. PubMed ID: 5956989 [No Abstract] [Full Text] [Related]